NCT04756180View on ClinicalTrials.gov

An Efficacy and Safety Study of Omega-3-acid Ethyl Ester in Chinese Subjects With Hypertriglyceridemia.

PHASE3CompletedINTERVENTIONAL
Enrollment

248

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

April 30, 2019

Study Completion Date

April 30, 2019

Conditions
Hypertriglyceridemia
Interventions
DRUG

Omega-3-acid ethyl ester or Placebo

Omega-3-acid ethyl ester 2 gm/day for first 4 week followed by 4gm/day for 8 week

Sponsors

Lead Sponsor

Abbott
All Listed Sponsors
lead

Abbott

INDUSTRY